JAN (NYSE:JAN) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

Stock analysts at JPMorgan Chase & Co. initiated coverage on shares of JAN (NYSE:JAN) in a report released on Tuesday, Marketbeat reports. The firm set an “overweight” rating and a $26.00 price target on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 8.32% from the company’s previous close.

JAN has been the topic of several other reports. Wall Street Zen upgraded JAN to a “hold” rating in a research note on Saturday, April 4th. KeyCorp began coverage on JAN in a research note on Tuesday. They set an “overweight” rating and a $28.00 target price on the stock. Morgan Stanley began coverage on JAN in a research note on Tuesday. They set an “overweight” rating and a $28.00 target price on the stock. Barclays began coverage on JAN in a research note on Tuesday. They set an “overweight” rating and a $26.00 target price on the stock. Finally, BNP Paribas Exane began coverage on JAN in a research note on Tuesday. They set an “outperform” rating and a $27.00 target price on the stock. Nine investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $27.20.

JAN Trading Up 0.6%

Shares of NYSE:JAN opened at $24.00 on Tuesday. JAN has a 12-month low of $22.76 and a 12-month high of $24.36. The firm has a market capitalization of $6.16 billion, a PE ratio of -62.29 and a beta of 2.16.

Insider Activity at JAN

In other news, Director John V. Arabia purchased 60,000 shares of the stock in a transaction on Monday, March 23rd. The stock was bought at an average price of $20.00 per share, with a total value of $1,200,000.00. Following the transaction, the director owned 67,500 shares in the company, valued at $1,350,000. The trade was a 800.00% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Charles J. Herman, Jr. purchased 5,500 shares of the stock in a transaction on Monday, March 23rd. The shares were purchased at an average cost of $20.00 per share, with a total value of $110,000.00. Following the transaction, the director owned 13,000 shares in the company, valued at $260,000. This trade represents a 73.33% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 187,000 shares of company stock worth $3,740,000 in the last quarter. 3.00% of the stock is owned by insiders.

Key Headlines Impacting JAN

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Cantor Fitzgerald initiated coverage with an Overweight rating and a $27 price target, which can prompt buying interest from investors and funds looking for analyst-backed ideas. Benzinga
• Neutral Sentiment: Technical/context: JAN’s 12?month trading range is narrow ($22.76–$24.36) and the stock recently opened near $24.00, so upside from new coverage could be constrained unless momentum or fundamentals shift.
• Neutral Sentiment: Risk/volatility note: market cap ~$6.16B with a negative P/E (-62.29) and a beta of 2.16 — the name can be volatile and sensitive to sentiment and analyst flows rather than steady earnings multiples.

About JAN

Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.